Stocks and Investing
Stocks and Investing
Wed, January 24, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, January 23, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
David Toung Upgraded (AMGN) to Strong Buy and Held Target at $220 on, Jan 23rd, 2018
David Toung of Argus Research, Upgraded "Amgen Inc." (AMGN) to Strong Buy and Held Target at $220 on, Jan 23rd, 2018.
David has made no other calls on AMGN in the last 4 months.
There are 4 other peers that have a rating on AMGN. Out of the 4 peers that are also analyzing AMGN, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Ian Somaiya of "BMO Capital" Maintained at Hold with Decreased Target to $192 on, Thursday, October 26th, 2017
- Geoff Meacham of "Barclays" Maintained at Hold with Increased Target to $190 on, Friday, October 13th, 2017
These are the ratings of the 2 analyists that currently disagree with David
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $193 on, Thursday, October 26th, 2017
- Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $186 on, Friday, September 29th, 2017
Contributing Sources